Resistance mutations found in those receiving GSK and Vir’s monoclonal for Delta, new research shows
While the Delta variant is in the rearview mirror now, new research from Australia shows how some people developed sotrovimab-resistant mutations following infusions with the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.